Detalles de la búsqueda
1.
Categorizing the characteristics of human carcinogens: a need for specificity.
Arch Toxicol
; 95(8): 2883-2889, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34148101
2.
The EU chemicals strategy for sustainability: in support of the BfR position.
Arch Toxicol
; 95(9): 3133-3136, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363510
3.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
Arch Toxicol
; 94(7): 2549-2557, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514609
4.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
J Toxicol Environ Health A
; 83(13-14): 485-494, 2020 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32552445
5.
Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
Regul Toxicol Pharmacol
; 115: 104711, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32598900
6.
Letter to the Editors regarding "10% body weight (gain) change as criterion for the maximum tolerated dose: A critical analysis".
Regul Toxicol Pharmacol
; 139: 105362, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828242
7.
A review of the carcinogenic potential of glyphosate by four independent expert panels and comparison to the IARC assessment.
Crit Rev Toxicol
; 46(sup1): 3-20, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677666
8.
Whither the impending european regulation of presumed endocrine disruptors?
Regul Toxicol Pharmacol
; 82: A1-A2, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27615676
9.
Bruce Nathan Ames - Paradigm shifts inside the cancer research revolution.
Mutat Res Rev Mutat Res
; 787: 108363, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34083041
10.
Obesity as a Source of Endogenous Compounds Associated With Chronic Disease: A Review.
Toxicol Sci
; 175(2): 149-155, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32207534
11.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Chem Biol Interact
; 326: 109099, 2020 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32370863
12.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Toxicol In Vitro
; 67: 104861, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360643
13.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Food Chem Toxicol
; 142: 111349, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360905
14.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Environ Toxicol Pharmacol
; 78: 103396, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32391796
15.
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology.
Toxicol Lett
; 340: 1-3, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33412252
16.
Corrigendum to "Critique of the "Comment" etitled "Pyrethroid exposure: not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinology".
Toxicol Lett
; 346: 57, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33902962
17.
Upholding science in health, safety and environmental risk assessments and regulations.
Toxicology
; 371: 12-16, 2016 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27639665
18.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Toxicol Lett
; 331: 259-264, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360654
19.
Atrazine and cancer: a review of the epidemiologic evidence.
Eur J Cancer Prev
; 22(2): 169-80, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22914097
20.
Allowing pseudoscience into EU risk assessment processes is eroding public trust in science experts and in science as a whole: The bigger picture.
Chem Biol Interact
; 257: 1-3, 2016 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27453574